Travis Alvin Thompson, Chief Financial Officer at Bicycle Therapeutics, sold BCYC on Jul 2, 2026
Data as of Oct 16
▼ SELL$3.5K819 shares at $4.27Travis Alvin Thompson Chief Financial OfficerBCYC Bicycle Therapeutics PLC
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filed
- 5 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
BCYC since disclosure
−21.0%
after the sale
Similar stocks (XLV) since disclosure
+7.5%
XLV — its sector index fund
Change in closing price from Jul 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLTravis Alvin Thompson Chief Financial OfficerBCYC Bicycle Therapeutics PLC$448disclosed Jul 7 · filed 1 day after the trade